Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...

Discovery brings us one step closer to vaccine and treatment for prevalent virus. Image courtesy of the Centers for Disease Control. Scientists at The University of Texas at Austin, in collaboration ...

Paul Griffin is a director and scientific advisory board member of the immunisation coalition. He has served on Medical Advisory Boards including for AstraZeneca, GSK, MSD, Moderna, Biocelect/Novavax, ...

Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...

The new Biovac Product Development Laboratory changes that reality — equipping scientists to handle the entire vaccine pipeline, from drug substance creation to large-scale production.

Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403. “Norovirus is a significant public health concern ...